Data / Form D filings / Auron Therapeutics, Inc.
Auron Therapeutics, Inc.: Form D filings
Auron Therapeutics, Inc., a biotechnology company in Wellesley, MA, filed 7 Form D notices with the SEC between 2018 and 2026. The latest, on August 13, 2026, reports $7.1 million sold of a $12 million offering to 14 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 1 Grove Street, Wellesley, MA, 02482
- Phone
- (310) 922-5881
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1746139
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Aug 13, 2026 | New notice | $12,000,000 | $7,118,141 | $4,881,859 | 14 | Aug 10, 2026 | sec.gov |
| Dec 23, 2025 | Amendment | $42,289,180 | $27,289,180 | $15,000,000 | 16 | Dec 18, 2024 | sec.gov |
| Dec 31, 2024 | New notice | $41,789,180 | $13,394,590 | $28,394,590 | 15 | Dec 18, 2024 | sec.gov |
| Oct 20, 2023 | Amendment | $48,249,997 | $38,399,997 | $9,850,000 | 10 | Jul 14, 2022 | sec.gov |
| Jul 28, 2022 | New notice | $48,249,997 | $25,999,998 | $22,249,999 | 10 | Jul 14, 2022 | sec.gov |
| Dec 16, 2020 | New notice | $15,441,157 | $15,441,157 | 25 | Dec 3, 2020 | sec.gov | |
| Jul 25, 2018 | New notice | $1,500,000 | $660,000 | $840,000 | 8 | Jun 12, 2018 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Katharine Yen | Executive Officer, Director | |
| Alexandra Cantley | Director | |
| Briggs Duncan Morrison | Director | |
| Anna French | Director | |
| Pini Orbach | Director | |
| Serge Messerlian | Director | |
| Victoria Richon | Director |
Other biotechnology companies in Massachusetts that filed recently
- Tru Singular Health, Inc. $1 million · Oct 30, 2026
- 511 Therapeutics, Inc. $500,000 · Oct 30, 2026
- Elucid Bioimaging Inc. $56.2 million · Oct 27, 2026
- OrthoIQ, Inc. $1.1 million · Oct 23, 2026
- LeanBio Therapeutics, Inc. offering · Oct 22, 2026
- Quiver Holdings Inc. $3 million · Oct 21, 2026
Every Form D from the week of Aug 10, 2026 · All recent filings in Massachusetts · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Auron Therapeutics, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.